The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Assessment of the Evolution of Cancer Treatment Therapies
Open accessAbstract
Cancer therapy has been characterized throughout history by ups and downs, not only due to the ineffectiveness of treatments and side effects, but also by hope and the reality of complete remission and cure in many cases. Within the therapeutic arsenal, alongside surgery in the case of solid tumors, are the antitumor drugs and radiation that have been the treatment of choice in some instances. In recent years, immunotherapy has become an important therapeutic alternative, and is now the first choice in many cases. Nanotechnology has recently arrived on the scene, offering nanostructures as new therapeutic alternatives for controlled drug delivery, for combining imaging and treatment, applying hyperthermia, and providing directed target therapy, among others. These therapies can be applied either alone or in combination with other components (antibodies, peptides, folic acid, etc.). In addition, gene therapy is also offering promising new methods for treatment. Here, we present a review of the evolution of cancer treatments, starting with chemotherapy, surgery, radiation and immunotherapy, and moving on to the most promising cutting-edge therapies (gene therapy and nanomedicine). We offer an historical point of view that covers the arrival of these therapies to clinical practice and the market, and the promises and challenges they present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
A clearer vision for in vivo imaging
Weissleder, R. (2001) · Nature Biotechnology · doi:10.1038/86684 · Cited by 3,839
Handbook of Pharmaceutical Excipients
Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (1994) · Cited by 3,493
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Plasmonic photothermal therapy (PPTT) using gold nanoparticles
Huang, X., Jain, P. K., El-Sayed, I. H., & El-Sayed, M. A. (2008) · Lasers in Medical Science · doi:10.1007/s10103-007-0470-x · Cited by 2,376
Nanoengineering of optical resonances
Oldenburg, S. J., Averitt, R. D., Westcott, S. L., & Halas, N. J. (1998) · Chemical Physics Letters · doi:10.1016/s0009-2614(98)00277-2 · Cited by 2,273
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201 · cited 1×
“[61] coupled PEGylated gold nanoparticles to a single-chain variable fragment antibody, which recognized the epidermal growth factor receptor overexpressed in many types of malignant human tumors, and demonstrated the targeting capabilities of these vectors in nude mice bearing human head-and-neck tumors.”
BackgroundA History of Cancer Chemotherapy
DeVita, V. T., & Chu, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6611 · Cited by 1,970
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds
HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603
EINHORN, L. H., & DONOHUE, J. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-3-293 · Cited by 1,545
Single-Chain Antigen-Binding Proteins
Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S.-M., Lee, T., Pope, S. H., Riordan, G. S., & Whitlow, M. (1988) · Science · doi:10.1126/science.3140379 · Cited by 1,502
Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease
DEVITA, V. T., SERPICK, A. A., & CARBONE, P. P. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-6-881 · Cited by 1,436
Optical-Thermal Response of Laser-Irradiated Tissue
(2011) · Springer eBooks · doi:10.1007/978-90-481-8831-4 · Cited by 1,424
Tyrosine Kinases as Targets for Cancer Therapy
Krause, D. S., & Van Etten, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044389 · Cited by 1,387
Nanoparticles in photodynamic therapy: An emerging paradigm
Chatterjee, D. K., Fong, L. S., & Zhang, Y. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.003 · Cited by 1,184
Intensity-modulated radiation therapy, protons, and the risk of second cancers
Hall, E. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.027 · Cited by 1,110
Computationally Guided Photothermal Tumor Therapy Using Long-Circulating Gold Nanorod Antennas
von Maltzahn, G., Park, J.-H., Agrawal, A., Bandaru, N. K., Das, S. K., Sailor, M. J., & Bhatia, S. N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4242 · Cited by 1,051
Magnetic nanoparticles for theragnostics
Shubayev, V. I., Pisanic, T. R., & Jin, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.007 · Cited by 1,028
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody
Miller, R. A., Maloney, D. G., Warnke, R., & Levy, R. (1982) · New England Journal of Medicine · doi:10.1056/nejm198203043060906 · Cited by 985
Assembly of a Functional Immunoglobulin F v Fragment in Escherichia coli
Skerra, A., & Plückthun, A. (1988) · Science · doi:10.1126/science.3285470 · Cited by 978
Inorganic nanoparticles as carriers for efficient cellular delivery
Xu, Z. P., Zeng, Q. H., Lu, G. Q., & Yu, A. B. (2006) · Chemical Engineering Science · doi:10.1016/j.ces.2005.06.019 · Cited by 976
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
Targeting nanoparticles to cancer
Wang, M., & Thanou, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.005 · Cited by 931
Roy, I., Ohulchanskyy, T. Y., Pudavar, H. E., Bergey, E. J., Oseroff, A. R., Morgan, J., Dougherty, T. J., & Prasad, P. N. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0343095 · Cited by 929
Chertok, B., Moffat, B. A., David, A. E., Yu, F., Bergemann, C., Ross, B. D., & Yang, V. C. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.050 · Cited by 900
Nabel, G. J., Nabel, E. G., Yang, Z. Y., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., & Chang, A. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11307 · Cited by 882
Transport of molecules across tumor vasculature
Jain, R. K. (1987) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00047468 · Cited by 866
Multifunctional nanoparticles – properties and prospects for their use in human medicine
Sanvicens, N., & Marco, M. P. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.04.005 · Cited by 833
Maier-Hauff, K., Rothe, R., Scholz, R., Gneveckow, U., Wust, P., Thiesen, B., Feussner, A., von Deimling, A., Waldoefner, N., Felix, R., et al. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9195-0 · Cited by 775
Nanoparticles as vehicles for delivery of photodynamic therapy agents
Bechet, D., Couleaud, P., Frochot, C., Viriot, M.-L., Guillemin, F., & Barberi-Heyob, M. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.07.007 · Cited by 760
Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions.
Hozumi, N., & Tonegawa, S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.10.3628 · Cited by 759
Optical-Thermal Response of Laser-Irradiated Tissue
(1995) · Springer eBooks · doi:10.1007/978-1-4757-6092-7 · Cited by 705
GOODMAN, L. S. (1946) · Journal of the American Medical Association · doi:10.1001/jama.1946.02870380008004 · Cited by 700
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697
PEGylation of therapeutic proteins
Jevševar, S., Kunstelj, M., & Porekar, V. G. (2010) · Biotechnology Journal · doi:10.1002/biot.200900218 · Cited by 681
Issels, R. D., Lindner, L. H., Verweij, J., Wust, P., Reichardt, P., Schem, B.-C., Abdel-Rahman, S., Daugaard, S., Salat, C., Wendtner, C.-M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70071-1 · Cited by 659
Nanotoxicity of iron oxide nanoparticle internalization in growing neurons
Pisanic, T. R., Blackwell, J. D., Shubayev, V. I., Fiñones, R. R., & Jin, S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.01.043 · Cited by 585
A Cellular Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors
Choi, M.-R., Stanton-Maxey, K. J., Stanley, J. K., Levin, C. S., Bardhan, R., Akin, D., Badve, S., Sturgis, J., Robinson, J. P., Bashir, R., et al. (2007) · Nano Letters · doi:10.1021/nl072209h · Cited by 584
Escherichia coli Secretion of an Active Chimeric Antibody Fragment
Better, M., Chang, C. P., Robinson, R. R., & Horwitz, A. H. (1988) · Science · doi:10.1126/science.3285471 · Cited by 579
THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.
JOHNSON, I. S., Jg, A., Gorman, M., & Jp, B. (1963) · PubMed · Cited by 564
ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE
Devita, V., Canellos, G., Chabner, B., Schein, P., Hubbard, S., & Young, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91142-3 · Cited by 484
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
Gullotti, E., & Yeo, Y. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900090z · Cited by 473
Magnetic nanoparticle hyperthermia for prostate cancer
Johannsen, M., Thiesen, B., Wust, P., & Jordan, A. (2010) · International Journal of Hyperthermia · doi:10.3109/02656731003745740 · Cited by 469
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma
Jordan, A., Scholz, R., Maier-Hauff, K., van Landeghem, F. K. H., Waldoefner, N., Teichgraeber, U., Pinkernelle, J., Bruhn, H., Neumann, F., Thiesen, B., et al. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9059-z · Cited by 459
Current Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of Cancers
Peng, Z. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1016 · Cited by 436
ANTAGONISTS OF NUCLEIC ACID DERIVATIVES
Elion, G. B., Singer, S., & Hitchings, G. H. (1954) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65573-5 · Cited by 427
Replicative adenoviruses for cancer therapy
Alemany, R., Balagué, C., & Curiel, D. T. (2000) · Nature Biotechnology · doi:10.1038/77283 · Cited by 421
Johannsen, M., Gneveckow, U., Taymoorian, K., Thiesen, B., Waldöfner, N., Scholz, R., Jung, K., Jordan, A., Wust, P., & Loening, S. A. (2007) · International Journal of Hyperthermia · doi:10.1080/02656730601175479 · Cited by 382
Gene delivery with synthetic (non viral) carriers
Brown, M. D., Schätzlein, A. G., & Uchegbu, I. F. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00861-4 · Cited by 367
Einhorn, L. H. (1981) · PubMed · Cited by 338
Tumor-targeted Delivery of siRNA by Self-assembled Nanoparticles
Li, S.-D., Chen, Y.-C., Hackett, M. J., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300323 · Cited by 333
Intracellular Hyperthermia for Cancer Using Magnetite Cationic Liposomes: An in vivo Study
Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., & Kobayashi, T. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00586.x · Cited by 322
Lu, W., Xiong, C., Zhang, G., Huang, Q., Zhang, R., Zhang, J. Z., & Li, C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1480 · Cited by 322
Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference
Tan, W. B., Jiang, S., & Zhang, Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.018 · Cited by 295
Clinical Trials with Oncolytic Adenovirus in China
Yu, W., & Fang, H. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780058817 · Cited by 274
Weng, K. C., Noble, C. O., Papahadjopoulos-Sternberg, B., Chen, F. F., Drummond, D. C., Kirpotin, D. B., Wang, D., Hom, Y. K., Hann, B., & Park, J. W. (2008) · Nano Letters · doi:10.1021/nl801488u · Cited by 273
CERVICAL CARCINOMA IN YOUNGER PATIENTS
Bouma, J., & Crane-Elders, A. B. F. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92628-4 · Cited by 263
Improvement of different vaccine delivery systems for cancer therapy
Bolhassani, A., Safaiyan, S., & Rafati, S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-3 · Cited by 239
ANTAGONISTS OF NUCLEIC ACID DERIVATIVES
Hitchings, G. H., Falco, E. A., Vanderwerff, H., Russell, P. B., & Elion, G. B. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)44808-9 · Cited by 235
(1949) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1949.tb68027.x · Cited by 215
Sun, C., Fang, C., Stephen, Z., Veiseh, O., Hansen, S., Lee, D., Ellenbogen, R. G., Olson, J., & Zhang, M. (2008) · Nanomedicine · doi:10.2217/17435889.3.4.495 · Cited by 213
Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells
Wu, & Zhang (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s10458 · Cited by 199
Non-Viral Nucleic Acid Delivery: Key Challenges and Future Directions
Elsabahy, M., Nazarali, A., & Foldvari, M. (2011) · Current Drug Delivery · doi:10.2174/156720111795256174 · Cited by 199
Thermoresponsive core–shell magnetic nanoparticles for combined modalities of cancer therapy
Purushotham, S., Chang, P. E. J., Rumpel, H., Kee, I. H. C., Ng, R. T. H., Chow, P. K. H., Tan, C. K., & Ramanujan, R. V. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/30/305101 · Cited by 197
Bernardi, R. J., Lowery, A. R., Thompson, P. A., Blaney, S. M., & West, J. L. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9467-3 · Cited by 189
Therapy of Choriocarcinoma and Related Trophoblastic Tumors with Folic Acid and Purine Antagonists
Li, M. C., Hertz, R., & Bergenstal, D. M. (1958) · New England Journal of Medicine · doi:10.1056/nejm195807102590204 · Cited by 189
Yan, F., & Kopelman, R. (2003) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2003)0780587teomis2.0.co2 · Cited by 171
Itô, A., Shinkai, M., Honda, H., et al. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700357 · Cited by 151
Kikumori, T., Kobayashi, T., Sawaki, M., & Imai, T. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9948-x · Cited by 151
Near‐Infrared‐Resonant Gold/Gold Sulfide Nanoparticles as a Photothermal Cancer Therapeutic Agent
Gobin, A. M., Watkins, E. M., Quevedo, E., Colvin, V. L., & West, J. L. (2010) · Small · doi:10.1002/smll.200901557 · Cited by 143
Fayter, D., Corbett, M., Heirs, M. K., Fox, D. C., & Eastwood, A. J. (2010) · Health Technology Assessment · doi:10.3310/hta14370 · Cited by 139
THE CHEMISTRY AND BIOCHEMISTRY OF PURINE ANALOGS
Hitchings, G. H., & Elion, G. B. (1954) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1954.tb40008.x · Cited by 136
Gene Therapy: The First Approved Gene-Based Medicines, Molecular Mechanisms and Clinical Indications
Räty, J. K., Pikkarainen, J. T., Wirth, T. C., & Ylä‐Herttuala, S. (2008) · Current Molecular Pharmacology · doi:10.2174/1874467210801010013 · Cited by 118
Kawai, N., Itô, A., Nakahara, Y., Futakuchi, M., Shirai, T., Honda, H., Kobayashi, T., & Kohri, K. (2005) · The Prostate · doi:10.1002/pros.20253 · Cited by 116
Anwer, K., Barnes, M. N., Fewell, J. G., Lewis, D. H., & Alvarez, R. D. (2009) · Gene Therapy · doi:10.1038/gt.2009.159 · Cited by 108
Evolution of the management of laryngeal cancer
Genden, E. M., Ferlito, A., Silver, C. E., Jacobson, A. S., Werner, J. A., Suarez, C. M., Leemans, C. R., Bradley, P. J., & Rinaldo, A. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.08.007 · Cited by 107
Scolnik, P. A. (2009) · mAbs · doi:10.4161/mabs.1.2.7736 · Cited by 102
Hattori, Y., & Maitani, Y. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700844 · Cited by 100
Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts
Yoshizawa, T., Hattori, Y., Hakoshima, M., Koga, K., & Maitani, Y. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.026 · Cited by 99
A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma
Bedikian, A. Y., Richards, J. M., Kharkevitch, D. D., Atkins, M. B., Whitman, E. D., & Gonzalez, R. C. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e3283390711 · Cited by 96
Genesis of endometrial carcinoma.II. Cases 19 to 35 years old
Sommers, S. C., Hertig, A. T., & Bengloff, H. (1949) · Cancer · doi:10.1002/1097-0142(194911)2:6<943::aid-cncr2820020602>3.0.co;2-p · Cited by 96
Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions
Lanza, G., Winter, P. M., Caruthers, S. D., Hughes, M. S., Hu, G., Schmieder, A. H., & Wickline, S. A. (2010) · Angiogenesis · doi:10.1007/s10456-010-9166-0 · Cited by 96
Combination chemotherapy in disseminated testicular cancer: the Indiana University experience.
Einhorn, L. H., & Donohue, J. P. (1979) · PubMed · Cited by 93
Nemunaitis, J. J., Clayman, G. L., Agarwala, S. S., Hrushesky, W. J. M., Wells, J. R., Moore, C. E., Hamm, J. T., Yoo, G. H., Baselga, J. M., Murphy, B. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1044 · Cited by 91
Griffin, R. J., Dings, R. P. M., Jamshidi‐Parsian, A., & Song, C. W. (2010) · International Journal of Hyperthermia · doi:10.3109/02656730903453546 · Cited by 90
Design of next-generation protein therapeutics
Caravella, J. A., & Lugovskoy, A. A. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.175 · Cited by 87
Intensive Combination Chemotherapy and X-Irradiation in Hodgkin's Disease
DeVita, V. T., DeVita-Raeburn, E., & Moxley, J. H. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0470 · Cited by 80
ElBakri, A. M. K., Nelson, P. N., & AbuOdeh, R. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.09.007 · Cited by 78
Kommareddy, S., & Amiji, M. M. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701041 · Cited by 77
A human myeloma cell line suitable for the generation of human monoclonal antibodies
Karpas, A., Dremucheva, A., & Czepulkowski, B. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1799 · Cited by 71
Sánchez, L., Ayala, M., Freyre, F., Pedroso, I., Bell, H., Falcón, V., & Gavilondo, J. (1999) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00036-x · Cited by 58
Regulatable Gene Expression Systems for Gene Therapy
Vilaboa, N. E., & Voellmy, R. W. (2006) · Current Gene Therapy · doi:10.2174/156652306777934829 · Cited by 52
Self-citationTranslation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers
Weichselbaum, R. R., & Kufe, D. W. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.37 · Cited by 41
Sitimagene Ceradenovec: A Gene-Based Drug for the Treatment of Operable High-Grade Glioma
van Putten, E. H. P., Dirven, C. M. F., van den Bent, M. J., & Lamfers, M. L. M. (2010) · Future Oncology · doi:10.2217/fon.10.134 · Cited by 32
Therapeutic applications of chemical warfare agents.
GILMAN, A. (1946) · PubMed · Cited by 25
Magadán, S., Valladares, M., Suárez, E., Sanjuán, I., Molina, A., AYLING, C. M., Davies, S. L., Zou, X., Williams, G. T., Neuberger, M. S., et al. (2002) · BioTechniques · doi:10.2144/02333dd04 · Cited by 24
Self-citationSUAREZ, E., Magadán, S., SANJUAN, I., Valladares, M., MOLINA, A., Gambón, F., Díaz‐Espada, F., & González‐Fernández, Á. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.10.015 · Cited by 16
Self-citationLehmann, J., Natarajan, A., DeNardo, G. L., Ivkov, R., Foreman, A. R., Catapano, C., Mirick, G. R., Quang, T. S., Gruettner, C., & DeNardo, S. J. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0411 · Cited by 14
Deliberate Regulation of Therapeutic Transgenes
Vilaboa, N. E., & Voellmy, R. W. (2008) · CRC Press eBooks · doi:10.1201/9780849387999.pt3 · Cited by 5
Self-citation
Cited by
New approaches and procedures for cancer treatment: Current perspectives
Debela, D. T., Muzazu, S. G., Heraro, K. D., Ndalama, M. T., Mesele, B. W., Haile, D. C., Kitui, S. K., & Manyazewal, T. (2021) · SAGE Open Medicine · doi:10.1177/20503121211034366 · Cited by 1,597
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Falzone, L., Salomone, S., & Libra, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01300 · Cited by 908
Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics
Chamoli, A., Gosavi, A. S., Shirwadkar, U. P., Wangdale, K. V., Behera, S. K., Kurrey, N. K., Kalia, K., & Mandoli, A. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105451 · Cited by 589
Cancer treatment therapies: traditional to modern approaches to combat cancers
Kaur, R., Bhardwaj, A., & Gupta, S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08809-3 · Cited by 561
Metadata
- Authors
- Arruebo, M., Vilaboa, N., Sáez-Gutierrez, B., Lambea, J., Tres, A., Valladares, M., & González-Fernández, Á.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2011-08-12
- Volume
- 3
- Issue
- 3
- Pages
- 3279-3330
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2035838265
- Cited by
- 931
- References
- 103
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.